Moderna
MRNA
#1709
Rank
NZ$16.08 B
Marketcap
$41.60
Share price
-1.89%
Change (1 day)
-76.22%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2024 (TTM): -NZ$6.08 Billion

According to Moderna 's latest financial reports the company's current earnings are NZ$3.19 Billion. , an increase over its 2023 earnings that were of -NZ$6.58 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2024

Annual earnings

Year Earnings Change
2024 -NZ$6.04 Billion-8.22%
2023 -NZ$6.58 Billion-140.65%
2022 NZ$16.16 B-27.81%
2021 NZ$22.38 B-1911.15%
2020 -NZ$1.24 Billion44.7%
2019 -NZ$0.86 Billion28.63%
2018 -NZ$0.67 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$77.76 Million-98.71%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$35.69 B-691.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$70.29 Million-98.83%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.4 Billion-93.43%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$22.95 B-480.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-NZ$1.02 Billion-83.25%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$29.35 B-586.80%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.2 Billion-96.72%๐Ÿ‡บ๐Ÿ‡ธ USA